Physician profile
Danielle Bertoni
NPI 1780843185
$5,613.47
in general payments reported to CMS, 2019-2025
59 companies · $2,748 in 2025
The $2,748 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $186 · 2023: $528 · 2024: $2,152 · 2025: $2,748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,389 · Entertainment: $28.37 · Travel and Lodging: $9.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,389.22 |
| Entertainment | $28.37 |
| Travel and Lodging | $9.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $618.52 | 2023-2025 | Imfinzi, Tagrisso, Calquence |
| Janssen Biotech, INC. | $552.14 | 2023-2025 | Erleada, Darzalex, Balversa |
| Merck Sharp & Dohme LLC | $457.03 | 2024-2025 | Keytruda, Lynparza, Welireg |
| Endomagnetics LTD | $321.83 | 2021-2024 | Magtrace, Magseed |
| Novartis Pharmaceuticals Corporation | $317.11 | 2024-2025 | |
| Genentech USA, INC. | $192.42 | 2023-2025 | Venclexta, Ocrevus, Tecentriq |
| Silk Road Medical, INC. | $172.44 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Telix Pharmaceuticals | $165.23 | 2023-2024 | Illuccix |
| Myriad Genetic Laboratories, INC. | $145.11 | 2023-2025 | Myrisk, Precisetumor |
| Hologic Sales and Service, LLC | $143.88 | 2023-2025 | Trident Specimen Radiography System, Trunode, Biozorb |
| Takeda Pharmaceuticals U.S.A., INC. | $143.43 | 2024-2025 | Iclusig, Ninlaro |
| Stemline Therapeutics INC. | $124.23 | 2024-2025 | Orserdu |
| Jazz Pharmaceuticals INC. | $113.11 | 2025 | |
| Astellas Pharma US INC | $109.10 | 2024-2025 | Xtandi, Padcev |
| Genmab U.S., INC. | $107.07 | 2024-2025 | Epkinly |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $105.01 | 2024-2025 | |
| Agios Pharmaceuticals, INC. | $82.84 | 2024-2025 | Pyrukynd |
| Servier Pharmaceuticals LLC | $82.52 | 2025 | |
| Abbvie INC. | $82.03 | 2024-2025 | |
| Medtronic, INC. | $81.82 | 2024 | Venaseal |
| Lilly USA, LLC | $79.01 | 2024-2025 | Verzenio, Jaypirca |
| Daiichi Sankyo INC. | $75.70 | 2025 | Enhertu, Datroway |
| Exelixis INC. | $75.19 | 2024-2025 | Cabometyx |
| Sobi, INC | $75.16 | 2024-2025 | |
| Molli Surgical (US) INC | $73.39 | 2023 | |
| Gilead Sciences, INC. | $64.79 | 2024-2025 | Trodelvy |
| Sumitomo Pharma America, INC. | $62.04 | 2023-2025 | Orgovyx |
| Eisai INC. | $61.66 | 2024-2025 | |
| Recordati_rare_diseases_inc. | $57.88 | 2024-2025 | Sylvant |
| Genzyme Corporation | $55.14 | 2025 | |
| Amgen INC. | $52.34 | 2023-2025 | Evenity, Prolia |
| Pfizer INC. | $49.10 | 2024-2025 | |
| Coherus Oncology, INC. | $48.97 | 2024-2025 | Loqtorzi |
| Boston Scientific Corporation | $45.47 | 2023-2024 | Spaceoar Vue System - 10ml |
| Genentech, INC. | $32.96 | 2024 | Columvi, Lunsumio |
| Glaxosmithkline, LLC. | $32.42 | 2025 | Zejula, Jemperli |
| Stryker Corporation | $28.95 | 2024 | Molli, Eikon, Spy-Phi System |
| Mentor Worldwide LLC | $28.76 | 2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Caris Mpi, INC. | $28.37 | 2025 | Mi Cancer Seek |
| Kub Technologies INC. | $28.37 | 2023 | Mozart |
| Kyowa Kirin, INC. | $27.97 | 2025 | |
| Pharmaessentia USA Corporation | $27.22 | 2025 | Besremi |
| Emd Serono, INC. | $26.59 | 2025 | |
| Mirati Therapeutics, INC. | $26.23 | 2024 | Krazati |
| Aveo Pharmaceuticals, INC. | $26.17 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $25.99 | 2025 | Libtayo |
| Adc Therapeutics America, INC. | $25.61 | 2024 | |
| Beone Medicines USA, INC. | $25.34 | 2025 | Brukinsa |
| Tactile Systems Technology INC | $23.58 | 2024 | Flexitouch Plus, Entre Plus |
| Taiho Oncology, INC. | $23.47 | 2024 | |
| Fennec Pharmaceuticals, INC. | $21.78 | 2025 | Fyarro |
| Argenx US, INC. | $21.77 | 2024 | Vyvgart Hytrulo |
| Karyopharm Therapeutics INC. | $21.59 | 2025 | Xpovio |
| Tersera Therapeutics LLC | $21.48 | 2025 | Xermelo |
| Legend Biotech USA INC. | $21.27 | 2025 | Carvykti |
| Spectrum Pharmaceuticals INC. | $19.14 | 2025 | Rolvedon |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.93 | 2025 | |
| Blue Earth Diagnostics | $18.76 | 2023 | |
| Invivyd INC | $18.04 | 2025 | Pemgarda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Bertoni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.